Drug
Perhexiline clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2009 (3)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 3 |
| 2016 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 6
University Hospital Birmingham (3) · Heart Metabolics Limited (2) · University of Aberdeen (1) · University Hospital Birmingham NHS Foundation Trust (1) · Flinders University (1)
Related medicines
As reviewed, each with the page that says it.
- One of Calcium Channel Blockers source
Studies
Open first, then newest update. How each study uses Perhexiline is read from its arms, and is right about nine times in ten.
Testing it · 8
- Role of Perhexiline in Hypertrophic CardiomyopathyStatus unknownPhase 2Flinders UniversityNCT04426578Written as Perhexiline
- Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart FailureTerminatedPhase 2Heart Metabolics LimitedNCT02862600Written as Perhexiline
- Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart FailureWithdrawnPhase 3Heart Metabolics LimitedNCT02431221Written as Perhexiline
- Perhexiline Therapy in Heart Failure With Preserved Ejection Fraction SyndromeCompletedPhase 2University of AberdeenNCT00839228Written as Perhexiline
- Metabolic Manipulation in Chronic Heart FailureCompletedPhase 2University Hospital Birmingham NHS Foundation TrustNCT00841139Written as Perhexiline
- Myocardial Protection With Perhexiline in Left Ventricular HypertrophyStatus unknownPhase 2/3University Hospital BirminghamNCT00989508Written as Perhexiline
- Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery SurgeryCompletedPhase 2/3University Hospital BirminghamNCT00845364Written as Perhexiline
- Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in DiabetesStatus unknownPhase 1/2University Hospital BirminghamNCT00628056Written as Perhexiline
Codes
What other systems call Perhexiline · ClinicalTrials.gg INT007984
- MeSH (NLM) D010480PerhexilineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) KU65374X44PERHEXILINEConfirmed FDA, NLM, Wikidata
- RxNorm 8050Confirmed FDA, Wikidata
- Wikidata Q1232737perhexilineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C170311PerhexilineOne source FDA
- DrugBank DB01074One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D010480 | Perhexiline | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | KU65374X44 | PERHEXILINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 8050 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1232737 | perhexiline | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C170311 | Perhexiline | One source FDA |
| DrugBank | DB01074 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.